YANAGISAWA; Masashi
Patent Applications and Registrations
Patent applications and USPTO patent grants for YANAGISAWA; Masashi.The latest application filed is for "sulfonamide derivative or pharmaceutically acceptable acid-addition salt".
- YANAGISAWA; Masashi - Tsukuba JP
- Yanagisawa; Masashi - Okazaki JP
- YANAGISAWA; Masashi - Okazaki-shi Aichi
- YANAGISAWA; Masashi - Tsukuba-shi JP
- Yanagisawa; Masashi - Dallas TX
- Yanagisawa; Masashi - Aichi-ken JP
- Yanagisawa; Masashi - Kanra-gun JP
- Yanagisawa; Masashi - Ibaraki JP
| Patent | Date |
|---|---|
| Sulfonamide Derivative Or Pharmaceutically Acceptable Acid-addition Salt App 20210078955 - NAGASE; Hiroshi ; et al. | 2021-03-18 |
| Former rotary dresser and dressing method Grant 10,537,976 - Nakano , et al. Ja | 2020-01-21 |
| Formed Rotary Dresser And Dressing Method App 20190358773 - NAKANO; Susumu ; et al. | 2019-11-28 |
| Morphinan derivative and medical usage thereof Grant 10,377,763 - Nagase , et al. A | 2019-08-13 |
| Sulfonamide derivative and pharmaceutically acceptable acid addition salt thereof Grant 10,351,522 - Nagase , et al. July 16, 2 | 2019-07-16 |
| Morphinan Derivative And Medical Usage Thereof App 20180305369 - NAGASE; Hiroshi ; et al. | 2018-10-25 |
| Sulfonamide Derivative And Pharmaceutically Acceptable Acid Addition Salt Thereof App 20180179151 - NAGASE; Hiroshi ; et al. | 2018-06-28 |
| Small-molecule agonists for type-2 orexin receptor Grant 8,871,794 - Yanagisawa October 28, 2 | 2014-10-28 |
| Small-molecule agonists for type-2 orexin receptor App 20140051700 - Yanagisawa; Masashi | 2014-02-20 |
| Small-molecule agonists for type-2 orexin receptor Grant 8,258,163 - Yanagisawa September 4, 2 | 2012-09-04 |
| Small-molecule agonists for type-2 orexin receptor App 20100150840 - Yanagisawa; Masashi | 2010-06-17 |
| Rotary Diamond Dresser App 20080041354 - Imal; Tomoyasu ; et al. | 2008-02-21 |
| Screening methods using ligands of the neutropeptide receptor HFGAN72 Grant 6,750,026 - Bergsma , et al. June 15, 2 | 2004-06-15 |
| cDNA clone MY1 that encodes a novel human 7-transmembrane receptor App 20030083466 - Yanagisawa, Masashi | 2003-05-01 |
| Screening methods using ligands of the neutropeptide receptor HFGAN72 App 20020082202 - Bergsma, Derk J. ; et al. | 2002-06-27 |
| Abrasive tool and the method of producing the same Grant 6,200,360 - Imai , et al. March 13, 2 | 2001-03-13 |
| Polynucleotides encoding MY1 receptor Grant 6,166,193 - Yanagisawa December 26, 2 | 2000-12-26 |
| Ligands of the neuropeptide receptor HFGAN72 Grant 6,001,963 - Bergsma , et al. December 14, 1 | 1999-12-14 |
| Drilling control apparatus of rock drill Grant 5,844,133 - Goto , et al. December 1, 1 | 1998-12-01 |
| Methods of screening of effectors of endothelin converting enzyme-1 Grant 5,688,640 - Yanagisawa November 18, 1 | 1997-11-18 |
| Endothelin DNA and use thereof Grant 5,294,569 - Masaki , et al. March 15, 1 | 1994-03-15 |
| Vasoconstrictor peptide Grant 4,981,950 - Masaki , et al. January 1, 1 | 1991-01-01 |
| NCAGE Code | 4EM19 | YANAGISAWA, MASASHI |
| CAGE Code | 4EM19 | YANAGISAWA, MASASHI |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 